Reversal of dialysis-dependent renal failure in light-chain deposition disease by autologous peripheral blood stem cell transplantation

American Journal of Kidney Diseases

Volumn 44, Issue 3, 2004, Pages 551-555

  Firkin, Frank ^a   Hill, Prudence A ^b   Dwyer, Karen ^b   Gock, Hilton ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

autologous peripheral blood stem cell transplantation; Light chain deposition disease (LCDD); renal failure

Indexed keywords

IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIALYSIS; ELECTRON MICROSCOPY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOPATHOLOGY; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; LABORATORY TEST; LIGHT CHAIN DEPOSITION DISEASE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; STEM CELL TRANSPLANTATION; TREATMENT INDICATION;

ANTINEOPLASTIC AGENTS, ALKYLATING; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; KIDNEY FAILURE, CHRONIC; MALE; MELPHALAN; MIDDLE AGED; PARAPROTEINEMIAS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REMISSION INDUCTION; RENAL DIALYSIS; TRANSPLANTATION, AUTOLOGOUS;

EID: 4444336030     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2004.05.031     Document Type: Article

References (11)

1. P.M. Ronco, M.A. Alyanakian, B. Mougenot, P. Aucouturier Light chain deposition disease A model of glomerulosclerosis defined at the molecular level J Am Soc Nephrol 12 2001 1558 1565
2. J. Lin, G.S. Markowitz, A.M. Valeri Renal monoclonal immunoglobulin deposition disease The disease spectrum J Am Soc Nephrol 12 2001 1482 1492
3. L.M. Knudsen, E. Hippe, M. Hjorth, E. Holmberg, J. Westin The Nordic Myeloma Study Group Renal function in newly diagnosed multiple myeloma A demographic study of 1353 patients Eur J Hematol 53 1994 207 212
4. C. Pozzi, F. Locatelli Kidney and liver involvement in monoclonal light chain disorders Semin Nephrol 22 2002 319 330
5. R.L. Heilman, J.A. Velosa, K.E. Holley, K.P. Offord, R.A. Kyle Long-term follow-up and response to chemotherapy in patients with light-chain deposition disease Am J Kidney Dis 20 1992 34 41
6. R.A. Kyle, M.A. Gertz, P.R. Greipp A trial of three regimens for primary amyloidosis Colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine N Engl J Med 336 1997 1202 1207
7. R.L. Comenzo, M.A. Gertz Autologous stem cell transplantation for primary systemic amyloidosis Blood 99 2002 4276 4282
8. G. Tricot, D.S. Alberts, C. Johnson Safety of autotransplants with high-dose melphalan in renal failure A pharmacokinetic and toxicity study Clin Cancer Res 2 1996 947 952
9. M. Nakamura, M. Satoh, S. Kowada Reversible restrictive cardiomyopathy due to light-chain deposition disease Mayo Clin Proc 77 2002 193 196
10. P. Barjon, J. Ribstein, G. Mourad, L.H. Noël, D. Maraninchiet, R. Bataille Traitment de la maladie par dépots de chaînes légères par greffe de moelle Néphrologie 13 1992 24 (abst)
11. X. Mariette, J.P. Clauvel, J.C. Brouet Intensive therapy in AL amyloidosis and light-chain deposition disease Ann Intern Med 123 1995 553 (letter)